Detected ·
VitriVax
$87MSeries C
VitriVax raised $87M in Series C financing to advance its single-dose Lyme disease vaccine into first-in-human trials and expand its vaccine pipeline.
- Website
- vitrivaxbio.com
- linkedin.com/company/35450798
- Amount
- $87 000 000 USD
- Stage
- Series C
- Event
- Funding round
- Detected
- 2026-11-19 08:03:40 UTC
- Signal ID
- 1594a6d5-5ef6-47b2-9a10-b91900a7651c
As the API returns it
{
"id": "1594a6d5-5ef6-47b2-9a10-b91900a7651c",
"created_at": "2026-11-19T08:03:40.876962Z",
"company_name": "VitriVax",
"company_website_url": "vitrivaxbio.com",
"company_linkedin_url": "https://www.linkedin.com/company/35450798",
"event_type": "funding",
"funding_amount": 87000000,
"funding_currency": "USD",
"funding_stage": "series_c",
"message": "*VitriVax raised $87M in Series C financing to advance its single-dose Lyme disease vaccine into first-in-human trials and expand its vaccine pipeline.*"
}